Old Web
English
Sign In
Acemap
>
authorDetail
>
Yuanfang Xu
Yuanfang Xu
Regeneron
Medicine
in patient
anti pd 1
Pathology
castration resistant
2
Papers
1
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Evaluation of Risk Scores to Predict Pediatric Severe Asthma Exacerbations
2021
The Journal of Allergy and Clinical Immunology: In Practice
Chao Niu
Yuanfang Xu
Christine L. Schuler
Lijuan Gu
Kavisha Arora
Yunjie Huang
Anjaparavanda P. Naren
Sandy R. Durrani
Monir Hossain
Theresa W. Guilbert
Show All
Source
Cite
Save
Citations (0)
A phase I/II study of REGN5678 (Anti-PSMAxCD28, a costimulatory bispecific antibody) with cemiplimab (anti-PD-1) in patients with metastatic castration-resistant prostate cancer.
2020
Journal of Clinical Oncology
Charles G. Drake
Jingsong Zhang
Mark N. Stein
Yuanfang Xu
Frank A. Seebach
Israel Lowy
Kosalai Kal Mohan
Glenn Kroog
Elizabeth Miller
Show All
Source
Cite
Save
Citations (1)
1